Autor: |
Rutherford DV; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Medley S; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA., Henderson NC; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA., Gersch CL; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Vandenberg TA; Western University/Canadian Cancer Trials Group, London, ON, N5X 3K8, Canada., Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA., Dakhil SR; Cancer Center of Kansas, Wichita, KS 67214, USA., Tirumali NR; Kaiser Permanente, Beaverton, OR 97005, USA., Gralow JR; American Society of Clinical Oncology, Alexandria, 22314, Virginia., Hortobagyi GN; University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA., Pusztai L; Yale School of Medicine, New Haven, CT 06510, USA., Mehta RS; University of California Irvine Medical Center, Chao Family Comprehensive Cancer Center, Orange, CA 92868, USA., Hayes DF; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Kidwell KM; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA., Henry NL; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Barlow WE; SWOG Statistical Center, Seattle, WA 98109, USA., Rae JM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA. |